Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| L-Theanine | Modafinil | |
|---|---|---|
| Category | Amino Acids | Nootropics |
| Standard Dose | 100-200mg daily (or as needed for acute anxiety/focus) | 100-200 mg once daily (for educational context only — prescription medication in most jurisdictions) |
| Timing | Flexible: morning for calm focus (stack with caffeine), before stressful events, or evening for relaxation/sleep onset. Onset: 30-60 minutes oral, 15-20 min sublingual. | Early morning to avoid insomnia; 1 hour before desired peak alertness. With or without food (food slows absorption by ~1 hour but does not reduce bioavailability). Half-life is approximately 12-15 hours. |
| Cycle Duration | ongoing or as needed | Not typically cycled in clinical use. Some off-label users cycle to maintain sensitivity (5 days on, 2 off; or as-needed use). |
| Evidence Level | strong_human | strong_human |
L-Theanine (gamma-glutamylethylamide) crosses the blood-brain barrier via the large neutral amino acid transporter. It increases alpha brain wave activity (8-13 Hz, associated with relaxed alertness), enhances GABA, serotonin, and dopamine levels in the brain, and antagonizes glutamate excitotoxicity by blocking glutamate binding at AMPA, kainate, and NMDA receptors. It also increases BDNF and NGF expression, supporting neuroplasticity. The combination of glutamate antagonism and GABA/serotonin enhancement produces anxiolysis without sedation — a 'calm focus' state.
100-200mg daily (or as needed for acute anxiety/focus)
Flexible: morning for calm focus (stack with caffeine), before stressful events, or evening for relaxation/sleep onset. Onset: 30-60 minutes oral, 15-20 min sublingual.
ongoing or as needed
Atypical eugeroic (wakefulness-promoting agent) that primarily inhibits the dopamine transporter (DAT), increasing extracellular dopamine in the prefrontal cortex and nucleus accumbens. This primary action cascades through multiple systems: indirect activation of orexinergic neurons in the lateral hypothalamus via potentiation of glutamatergic transmission; downstream stimulation of histaminergic neurons in the tuberomammillary nucleus (via orexin-mediated disinhibition of GABAergic inputs); and enhancement of norepinephrine release in the locus coeruleus. The net effect is broad-spectrum arousal without the peripheral sympathomimetic effects of classical stimulants.
100-200 mg once daily (for educational context only — prescription medication in most jurisdictions)
Early morning to avoid insomnia; 1 hour before desired peak alertness. With or without food (food slows absorption by ~1 hour but does not reduce bioavailability). Half-life is approximately 12-15 hours.
Not typically cycled in clinical use. Some off-label users cycle to maintain sensitivity (5 days on, 2 off; or as-needed use).
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →